LYMPHOCYTE INHIBITION BY HLA PEPTIDES

摘要

Novel peptides are provided for modulating the cytotoxic effect of CTL's. Novel peptides cross reactive with the C-terminal or N-terminal portions of the α, or α2 domains, respectively, of the MHC antigen providing the CTL restriction are employed for CTL modulation. The peptides may be used in vivo or in vitro for controlling cellular lysis.